🌿 NORML's Deputy Director Paul Armentano added: “These findings add to the growing body of evidence that cannabis is effective in the treatment of multiple conditions, including chronic pain, and that it possesses a safety profile that is often superior to traditional medications, like opioids. As legal access continues to expand, one would expect more patients to integrate cannabis products into their pain management strategies in a manner that reduces their overall disease burden as well as their reliance on opioids and other analgesic medications." (fb)

🚨 "At best, these are distortions based upon outliers and cherry-picked data," Paul Armentano, deputy director of NORML, told Marijuana Moment. "At worst, these memes are misinformation and propaganda." "Unfortunately, agencies like the DEA no longer have credibility with the public when it comes to providing guidance on these matters because of their longstanding politicization of cannabis and cannabis consumers. They are not honest brokers and the public knows it. So audiences—whether they're consumers or not—largely reject what they have to say, with good reason." (fb)